CVS HEALTH Corp (CVS) Latest Company News

Jul 16, 2026, 17:55 UTC
The Federal Trade Commission announced a multibillion-dollar settlement with CVS Caremark that is expected to lower prescription costs for consumers by changing how certain drug rebates are handled.
Source:
- yahoo.com
- statnews.com
Jul 15, 2026, 09:00 UTC
U.S. Senators Richard Blumenthal and Josh Hawley requested internal records and detailed information from UnitedHealth Group, Humana, and CVS Health regarding their use of artificial intelligence to deny rehabilitative care in Medicare Advantage plans.
Source:
- statnews.com
- medicaldaily.com
Jul 12, 2026, 18:00 UTC
CVS Health sued in federal court to block Tennessee's new law aimed at preventing health insurers from managing prescription benefits and running pharmacies.
Source:
- seattletimes.com
Jul 10, 2026, 13:48 UTC
CVS Health's board of directors approved a quarterly dividend of $0.665 per share.
Source:
- prnewswire.com
- marketscreener.com
Jul 9, 2026, 19:52 UTC
Lupin Pharmaceuticals Inc. voluntarily recalled 2.5 million bottles of prednisolone acetate ophthalmic suspension due to FDA concerns over sterility from a foreign substance.
Source:
- houstonchronicle.com
Jul 8, 2026, 13:30 UTC
CVS agreed to pay $37.76 million and admitted responsibility to settle a healthcare fraud lawsuit brought by the US Department of Justice for overbilling government health programs for insulin between 2010 and 2020.
Source:
- ibtimes.co.uk
- finance.yahoo.com
Jun 28, 2026, 23:59 UTC
At least a dozen U.S. states passed laws in 2025 to regulate pharmacy benefit managers, including limiting compensation, setting minimum payments to pharmacists, and requiring more disclosure.
Source:
- columbian.com
Jun 28, 2026, 23:59 UTC
CVS Health Corp. filed a federal lawsuit to challenge a Tennessee law that will bar pharmacy benefit managers from operating retail pharmacies as of July 1, 2028.
Source:
- columbian.com
Jun 25, 2026, 14:04 UTC
CVS Caremark declined to add ARS Pharmaceuticals' epinephrine spray Neffy to its formulary.
Source:
- investors.com
Jun 23, 2026, 23:59 UTC
Florida Attorney General James Uthmeier launched an investigation into CVS Health and its pharmacy benefit manager Caremark over concerns of unfair competitive practices affecting independent pharmacies and consumer choice.
Source:

← PreviousPage 3

CVS

The Federal Trade Commission announced a multibillion-dollar settlement with CVS Caremark that is expected to lower prescription costs for consumers by changing how certain drug rebates are handled.

U.S. Senators Richard Blumenthal and Josh Hawley requested internal records and detailed information from UnitedHealth Group, Humana, and CVS Health regarding their use of artificial intelligence to deny rehabilitative care in Medicare Advantage plans.

CVS Health sued in federal court to block Tennessee's new law aimed at preventing health insurers from managing prescription benefits and running pharmacies.

CVS Health's board of directors approved a quarterly dividend of $0.665 per share.

Lupin Pharmaceuticals Inc. voluntarily recalled 2.5 million bottles of prednisolone acetate ophthalmic suspension due to FDA concerns over sterility from a foreign substance.

CVS agreed to pay $37.76 million and admitted responsibility to settle a healthcare fraud lawsuit brought by the US Department of Justice for overbilling government health programs for insulin between 2010 and 2020.

At least a dozen U.S. states passed laws in 2025 to regulate pharmacy benefit managers, including limiting compensation, setting minimum payments to pharmacists, and requiring more disclosure.

CVS Health Corp. filed a federal lawsuit to challenge a Tennessee law that will bar pharmacy benefit managers from operating retail pharmacies as of July 1, 2028.

CVS Caremark declined to add ARS Pharmaceuticals' epinephrine spray Neffy to its formulary.

Florida Attorney General James Uthmeier launched an investigation into CVS Health and its pharmacy benefit manager Caremark over concerns of unfair competitive practices affecting independent pharmacies and consumer choice.